scanX
Home
Samrat Pharmachem

Samrat Pharmachem

497.00
+17.10
(3.56%)
Market Cap (₹ Cr.)
₹148
52 Week High
646.00
Book Value
₹
52 Week Low
320.00
PE Ratio
41.02
PB Ratio
2.28
PE for Sector
43.22
PB for Sector
21.19
ROE
26.34 %
ROCE
4.91 %
Dividend Yield
0.21 %
EPS
₹7.00
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-9.05 %
Net Income Growth
-87.00 %
Cash Flow Change
199.68 %
ROE
-87.37 %
ROCE
-87.65 %
EBITDA Margin (Avg.)
-82.64 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
9
13
13
17
20
21
19
18
13
20
21
25
27
25
23
27
37
36
37
35
30
35
42
55
48
47
59
56
60
87
71
84
69
58
80
62
83
81
Expenses
9
12
13
16
20
21
18
17
12
19
20
23
25
24
22
27
34
33
34
34
29
34
39
52
45
46
55
47
50
74
63
81
70
57
80
62
81
78
EBITDA
0
0
0
0
0
1
1
1
1
1
1
2
2
0
0
1
2
3
2
1
1
2
3
3
2
2
4
9
10
13
8
4
-0
1
1
1
2
3
Operating Profit %
0 %
2 %
2 %
2 %
2 %
3 %
5 %
7 %
8 %
6 %
4 %
9 %
5 %
1 %
1 %
3 %
5 %
8 %
6 %
2 %
3 %
5 %
6 %
4 %
4 %
3 %
7 %
16 %
17 %
15 %
12 %
4 %
-1 %
1 %
0 %
0 %
2 %
3 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
Profit Before Tax
-0
0
0
0
0
0
1
1
1
1
1
2
1
0
-0
0
2
3
2
1
1
1
2
2
2
1
4
9
10
13
8
3
-1
1
0
0
1
3
Tax
-0
0
0
0
0
0
0
0
1
0
0
1
1
0
-0
0
1
1
1
0
0
0
1
0
0
0
1
2
3
3
2
0
0
0
0
0
-0
1
Net Profit
-0
0
0
0
0
0
1
1
0
1
1
1
1
0
-0
0
1
2
2
0
0
1
1
2
2
1
3
6
7
9
6
2
-1
1
-0
0
1
2
EPS in ₹
-0.29
0.23
0.14
0.03
0.57
0.81
1.63
2.04
1.21
1.93
1.65
4.56
2.27
0.14
-0.29
0.92
4.21
6.05
4.86
1.52
1.27
2.58
4.66
4.97
5.05
3.09
9.03
20.87
22.64
30.32
19.14
6.78
-2.41
1.98
-0.61
1.11
4.52
6.68
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
26
36
36
41
40
58
57
85
117
122
Fixed Assets
7
7
7
7
7
7
9
10
11
11
Current Assets
18
28
28
33
33
50
47
71
99
103
Capital Work in Progress
0
0
0
0
0
1
0
0
0
0
Investments
0
2
0
0
0
0
0
0
2
3
Other Assets
19
27
29
34
33
50
48
75
104
108
Total Liabilities
13
22
21
22
20
34
28
38
53
57
Current Liabilities
12
20
19
21
19
34
27
37
53
56
Non Current Liabilities
1
2
2
1
1
0
0
0
0
0
Total Equity
13
14
15
19
20
24
30
47
63
65
Reserve & Surplus
10
11
12
15
17
21
27
44
60
62
Share Capital
3
3
3
3
3
3
3
3
3
3
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
-0
-1
-1
1
-1
-0
14
-3
-2
Investing Activities
0
-2
1
-2
2
-2
-3
-1
-3
-0
Operating Activities
-1
-0
-3
0
2
-1
5
17
-9
9
Financing Activities
0
2
1
2
-4
2
-2
-2
10
-11
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
49.30 %
49.30 %
49.30 %
49.65 %
49.65 %
49.65 %
49.54 %
48.64 %
48.64 %
48.64 %
48.64 %
48.64 %
48.64 %
48.64 %
48.95 %
FIIs
3.24 %
3.24 %
3.24 %
0.00 %
0.00 %
3.24 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
3.24 %
3.24 %
0.00 %
3.24 %
3.24 %
3.24 %
3.24 %
3.24 %
3.66 %
3.45 %
3.45 %
3.45 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
47.46 %
47.46 %
47.46 %
47.12 %
47.12 %
47.12 %
47.23 %
48.13 %
48.13 %
48.13 %
48.13 %
47.70 %
47.91 %
47.91 %
47.59 %

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,808.90 4,45,964.38 39.78 49,887.17 12.06 9,648 27.35 38.02
Divis Laboratories
5,901.75 1,56,653.02 93.58 8,184.00 0.89 1,600 20.79 59.92
Cipla
1,584.60 1,25,920.28 27.28 26,520.66 14.17 4,155 12.95 53.72
Mankind Pharma
2,731.20 1,07,795.31 54.93 10,615.63 19.57 1,942 9.89 60.78
Zydus Life Science
1,004.45 1,01,025.89 24.23 19,831.50 13.82 3,831 30.78 39.94
Lupin
2,188.35 1,00,283.05 44.30 20,141.50 19.94 1,936 77.69 50.98
Aurobindo Pharma
1,407.20 82,095.86 22.89 29,559.25 17.55 3,169 61.17 35.60
Alkem Laboratories
5,798.30 69,440.36 32.30 12,978.42 9.84 1,811 91.18 38.79
Glenmark Pharmaceuticals
1,699.25 47,716.61 - 12,653.09 6.58 -1,831 96.52 49.67
IPCA Laboratories
1,585.35 40,808.32 69.51 7,829.81 22.92 529 21.35 53.46

Corporate Action

Technical Indicators

RSI(14)
Neutral
48.79
ATR(14)
Volatile
32.06
STOCH(9,6)
Neutral
35.80
STOCH RSI(14)
Neutral
54.74
MACD(12,26)
Bearish
-4.10
ADX(14)
Weak Trend
18.67
UO(9)
Bearish
49.20
ROC(12)
Downtrend But Slowing Down
-8.13
WillR(14)
Neutral
-54.07
Bearish
4
Neutral
5
Bullish
0
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.